Literature DB >> 8793997

Recognition events that inhibit and activate natural killer cells.

D H Raulet1.   

Abstract

Natural killer (NK) cells exhibit specificity for MHC class I molecules in their interactions with target cells. Instead of activating the cells, the recognition of class I molecules on target cells inhibits NK-cell lytic activity, suggesting that surveillance of normal class I expression by body cells represents a key NK-cell function. Recent advances have been made in identification of the class I specific receptors expressed by NK cells, and in the characterization of their detailed specificity and expression patterns. Other studies are beginning to unravel recognition events that activate NK cells.

Mesh:

Substances:

Year:  1996        PMID: 8793997     DOI: 10.1016/s0952-7915(96)80127-0

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  4 in total

1.  The intertransmembrane region of Kaposi's sarcoma-associated herpesvirus modulator of immune recognition 2 contributes to B7-2 downregulation.

Authors:  Mizuho Kajikawa; Pai-Chi Li; Eiji Goto; Naoyuki Miyashita; Masami Aoki-Kawasumi; Mari Mito-Yoshida; Mika Ikegaya; Yuji Sugita; Satoshi Ishido
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

2.  Impact of a functional KIR2DS4 allele on heterosexual HIV-1 transmission among discordant Zambian couples.

Authors:  Aimee Merino; Rakhi Malhotra; Matt Morton; Joseph Mulenga; Susan Allen; Eric Hunter; Jianming Tang; Richard A Kaslow
Journal:  J Infect Dis       Date:  2011-01-07       Impact factor: 5.226

3.  Selection and adaptation of cells expressing major histocompatibility complex class I-specific receptors of the natural killer complex.

Authors:  A Bendelac
Journal:  J Exp Med       Date:  1997-08-04       Impact factor: 14.307

Review 4.  Memory-Like NK Cells: Remembering a Previous Activation by Cytokines and NK Cell Receptors.

Authors:  Jens H W Pahl; Adelheid Cerwenka; Jing Ni
Journal:  Front Immunol       Date:  2018-11-28       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.